| Description | The mAb is a recombinant rabbit antibody that recognizes Rift Valley Fever Virus (RVFV) Gn. The specificity of the original form of the clone was confirmed by ELISA analysis. This antibody was able to neutralize RVFV in vitro. The antibody neutralizes RVFV in the plaque reduction neutralization test (PRNT) with median inhibitory concentration (IC50) values ranging from 2.1 to 3.0 μg/mL. The antibody protects against RVFV challenge in a mouse infection model. |
| Clonality | Monoclonal |
| Host Species | Rabbit |
| Target Species | Rift Valley Fever Virus (RVFV) |
| Isotype | IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; Neut; PRNT; FuncS |
| Application Notes | Plaque reduction neutralization test (PRNT): IC50 values ranging from 2.1 to 3.0 μg/mL. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | RVFV Gn |
| Alternative Name | Rift valley fever virus; RVFV; Rift valley fever virus glycoprotein Gn |
